Matches in Wikidata for { <http://www.wikidata.org/entity/Q57260244> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q57260244 description "article scientifique publié en 2018" @default.
- Q57260244 description "artículu científicu" @default.
- Q57260244 description "im Juni 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57260244 description "wetenschappelijk artikel" @default.
- Q57260244 description "наукова стаття, опублікована в червні 2018" @default.
- Q57260244 name "Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study" @default.
- Q57260244 name "Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study" @default.
- Q57260244 type Item @default.
- Q57260244 label "Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study" @default.
- Q57260244 label "Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study" @default.
- Q57260244 prefLabel "Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study" @default.
- Q57260244 prefLabel "Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study" @default.
- Q57260244 P1433 Q57260244-08727F93-2FAC-4EAC-B972-073E7139D628 @default.
- Q57260244 P1476 Q57260244-5F96C320-FC15-4F82-9651-1FEA621DA25B @default.
- Q57260244 P2093 Q57260244-0BC28C56-8CBA-4C96-A9A2-AFE35FCA8586 @default.
- Q57260244 P304 Q57260244-F8DD5DA7-6C2D-4F44-AFD3-660F7B997ED3 @default.
- Q57260244 P31 Q57260244-7772C0DA-BE09-4646-964F-EC0B1240547A @default.
- Q57260244 P356 Q57260244-D8DAA152-E885-45BC-9463-ACA66CC529B1 @default.
- Q57260244 P433 Q57260244-CB70B673-D214-4406-A815-D77B08EAE939 @default.
- Q57260244 P478 Q57260244-93F9BC65-8363-4374-A336-88F46D74DC59 @default.
- Q57260244 P50 Q57260244-44B71509-0E0A-46E3-B5F9-49908935C4EC @default.
- Q57260244 P50 Q57260244-584562C6-B141-4CE7-A9DD-4EFB703E75BB @default.
- Q57260244 P50 Q57260244-7B4A7784-2C25-4F61-BD9C-C83228751AF5 @default.
- Q57260244 P50 Q57260244-87D4B75E-4EB5-40D3-8F5E-DAB4CE234995 @default.
- Q57260244 P50 Q57260244-C32DB7C6-F42D-437C-8229-88F6964233EA @default.
- Q57260244 P50 Q57260244-CE69486B-1AE5-4F95-9C96-C1E725320B6F @default.
- Q57260244 P50 Q57260244-DB840760-1DB9-43F8-89CB-19E59AAF2E93 @default.
- Q57260244 P577 Q57260244-8E8F4501-332A-486A-8F3B-96F03043DB8E @default.
- Q57260244 P698 Q57260244-53953281-1C9A-4A99-8051-580AF8E1287D @default.
- Q57260244 P921 Q57260244-1574FB60-60F8-438D-9CF0-4355106A55D9 @default.
- Q57260244 P921 Q57260244-1FD57F3A-3E6C-4A49-8B75-88A5AA017262 @default.
- Q57260244 P356 PVY021 @default.
- Q57260244 P698 29945162 @default.
- Q57260244 P1433 Q27726932 @default.
- Q57260244 P1476 "Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study" @default.
- Q57260244 P2093 "Jeffrey S Berger" @default.
- Q57260244 P304 "220-227" @default.
- Q57260244 P31 Q13442814 @default.
- Q57260244 P356 "10.1093/EHJCVP/PVY021" @default.
- Q57260244 P433 "4" @default.
- Q57260244 P478 "4" @default.
- Q57260244 P50 Q116772541 @default.
- Q57260244 P50 Q33310590 @default.
- Q57260244 P50 Q33310632 @default.
- Q57260244 P50 Q61152617 @default.
- Q57260244 P50 Q78699620 @default.
- Q57260244 P50 Q95949268 @default.
- Q57260244 P50 Q96207412 @default.
- Q57260244 P577 "2018-06-26T00:00:00Z" @default.
- Q57260244 P698 "29945162" @default.
- Q57260244 P921 Q414462 @default.
- Q57260244 P921 Q9397786 @default.